Date published: 2025-10-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

Chymostatin (CAS 9076-44-2)

5.0(1)
Write a reviewAsk a question

See product citations (3)

Alternate Names:
[(S)-1-Carboxy-2-phenylethyl]-carbamoyl-a-[2-amidohexahydro-4(S)-pyrimidyl]-(S)-glycyl-[A= LeuB=Val C=Ile]-phenylalaninal
Application:
Chymostatin is an inhibitor of chymotrypsin, papain, and cathepsin G, A, B, H, and L
CAS Number:
9076-44-2
Molecular Weight:
607.7
Molecular Formula:
C31H41N7O6
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Chymostatin is a bioactive peptide protease inhibitor that contains chymostatin A as a major form. The compound specifically inhibits chymotrypsin (CTR) (ID50 = 150 etag/ml), papain (ID50 = 7.5 mug/ml), and cathepsin G along with most cysteine proteases such as cathepsin A, B, H, and L. The compound has been noted as a strong inhibitor of cathepsins A, B, and C. Chymostatin at an effective concentration of 10 to 100 muM weakly inhibits human leukocyte Elastase-1. In rat muscle homogenates chymostatin inhibited the protease cathepsin B and other soluble Ca2+ activated proteases. In the same study, chymostatin decreased protein break down by 20-40% without inhibiting protein production.


Chymostatin (CAS 9076-44-2) References

  1. The inhibition of human leucocyte elastase and chymotrypsin-like protease by elastatinal and chymostatin.  |  Feinstein, G., et al. 1976. Biochim Biophys Acta. 429: 925-32. PMID: 1083745
  2. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells.  |  Murakami, T., et al. 1991. Biochim Biophys Acta. 1079: 279-84. PMID: 1911851
  3. Effects of chymostatin, a chymase inhibitor, on blood pressure, plasma and tissue angiotensin II, renal haemodynamics and renal excretion in two models of hypertension in the rat.  |  Roszkowska-Chojecka, MM., et al. 2015. Exp Physiol. 100: 1093-105. PMID: 26011164
  4. The effect of analogues of chymostatin on lysosomal and non-lysosomal components of protein degradation in isolated hepatocytes.  |  Place, GA., et al. 1987. Biochim Biophys Acta. 925: 185-93. PMID: 2887208
  5. Protective Effects of Chymostatin on Paraquat-Induced Acute Lung Injury in Mice.  |  Yang, C., et al. 2018. Inflammation. 41: 122-133. PMID: 28940034
  6. Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells.  |  Qiu, M., et al. 2018. Lipids Health Dis. 17: 183. PMID: 30064425
  7. Decoding the Papain Inhibitor from Streptomyces mobaraensis as Being Hydroxylated Chymostatin Derivatives: Purification, Structure Analysis, and Putative Biosynthetic Pathway.  |  Juettner, NE., et al. 2020. J Nat Prod. 83: 2983-2995. PMID: 32998509
  8. Chymostatin has no apparent beneficial effect on muscular dystrophy in the mdx mouse.  |  Christie, KN. 1988. J Neurol Sci. 84: 341-6. PMID: 3379449
  9. Beneficial effect of chymostatin on dystrophic mice.  |  Komatsu, K., et al. 1986. Exp Neurol. 93: 110-6. PMID: 3732454
  10. The structure of chymostatin, a chymotrypsin inhibitor.  |  Tatsuta, K., et al. 1973. J Antibiot (Tokyo). 26: 625-46. PMID: 4792111
  11. Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes.  |  Umezawa, H., et al. 1970. J Antibiot (Tokyo). 23: 425-7. PMID: 5453321
  12. Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.  |  Libby, P. and Goldberg, AL. 1980. Biochem J. 188: 213-20. PMID: 7406880

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Chymostatin, 5 mg

sc-202541
5 mg
$153.00

Chymostatin, 10 mg

sc-202541A
10 mg
$255.00

Chymostatin, 25 mg

sc-202541B
25 mg
$627.00

Chymostatin, 50 mg

sc-202541C
50 mg
$1163.00

Chymostatin, 100 mg

sc-202541D
100 mg
$2225.00